HK1000912A1 - Preparation of liposome and lipid complex compositions - Google Patents

Preparation of liposome and lipid complex compositions

Info

Publication number
HK1000912A1
HK1000912A1 HK97102512A HK97102512A HK1000912A1 HK 1000912 A1 HK1000912 A1 HK 1000912A1 HK 97102512 A HK97102512 A HK 97102512A HK 97102512 A HK97102512 A HK 97102512A HK 1000912 A1 HK1000912 A1 HK 1000912A1
Authority
HK
Hong Kong
Prior art keywords
liposome
compounds
aprotic solvent
preparation
lipid complex
Prior art date
Application number
HK97102512A
Other languages
English (en)
Inventor
Francis C Szoka
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of HK1000912A1 publication Critical patent/HK1000912A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK97102512A 1989-03-31 1997-12-19 Preparation of liposome and lipid complex compositions HK1000912A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33260989A 1989-03-31 1989-03-31
US33405589A 1989-04-05 1989-04-05
PCT/US1990/001646 WO1990011780A1 (fr) 1989-03-31 1990-03-28 Preparation de compositions complexes de liposomes et de lipides

Publications (1)

Publication Number Publication Date
HK1000912A1 true HK1000912A1 (en) 1998-05-08

Family

ID=26988293

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102512A HK1000912A1 (en) 1989-03-31 1997-12-19 Preparation of liposome and lipid complex compositions

Country Status (12)

Country Link
EP (1) EP0467954B1 (fr)
JP (1) JP2798302B2 (fr)
AT (1) ATE137403T1 (fr)
AU (1) AU638245B2 (fr)
CA (1) CA2050679C (fr)
DE (1) DE69026820T2 (fr)
DK (1) DK0467954T3 (fr)
ES (1) ES2087151T3 (fr)
HK (1) HK1000912A1 (fr)
HU (1) HU208070B (fr)
NO (1) NO303205B1 (fr)
WO (1) WO1990011780A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
JPH0363298A (ja) * 1989-07-31 1991-03-19 Green Cross Corp:The コロニー形成刺激因子・脂質複合体
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
DE4238779A1 (de) * 1992-11-12 1994-05-19 Max Delbrueck Centrum Lyotrophe Mesophasen und ihre Anwendung in der Pharmazie, der Kosmetik und der Dermatologie
ATE199640T1 (de) 1993-07-08 2001-03-15 Liposome Co Inc Verfahren zum kontrollieren der liposomengrösse
DE69434623T2 (de) * 1993-09-29 2006-07-27 Dsm Ip Assets B.V. Modifizierte Formen des Natamycins, Verfahren zu ihrer Herstellung und sie enthaltende antifungale Zusammensetzungen
CA2223179A1 (fr) * 1995-06-07 1996-12-19 Bob Dale Brown Nouveaux lipides cationiques a base d'acide phosphonique
AU773618B2 (en) * 1998-12-22 2004-05-27 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Water-insoluble drug delivery system
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
EP1334718A4 (fr) * 2000-10-26 2007-07-18 Senju Pharma Co Composition medicamenteuse contenant un compose dipeptidyl aldehyde
AU2002219998B2 (en) * 2000-12-01 2006-03-02 Biomira, Inc. Preparation of large liposomes by infusion into peg
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
EP2146692A1 (fr) * 2007-03-19 2010-01-27 Fresenius Kabi Oncology Limited Compositions proliposomales et liposomales
EP2219587A4 (fr) * 2007-11-14 2012-11-21 Univ California Lipides amphiphiles modifiés par un stérol
US9750812B2 (en) 2008-09-27 2017-09-05 Jina Pharmaceuticals, Inc. Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
KR101801426B1 (ko) 2010-07-14 2017-12-20 인스티투트 오브 마타리아 메디카, 차이니즈 아카데미 오브 메디칼 사이언스 인슐린-지질 복합물 및 그의 제조방법과 그의 제제
EP3177269A4 (fr) * 2014-08-04 2018-02-28 Zoneone Pharma, Inc. Chargement à distance de médicaments modérément hydrosolubles dans des vésicules lipidiques
CN113616798A (zh) * 2021-09-06 2021-11-09 天津农学院 一种甲苯咪唑脂质复合物、制备方法和应用
CN115177590A (zh) * 2022-04-20 2022-10-14 南昌大学抚州医学院 一种甲苯达唑类脂质体的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPS60240634A (ja) 1984-05-08 1985-11-29 関　則雄 飲み干し容易なコツプ
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4812312A (en) * 1987-03-03 1989-03-14 Board Of Regents Of The University Of Texas System Liposome-incorporated nystatin
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity

Also Published As

Publication number Publication date
JP2798302B2 (ja) 1998-09-17
HU208070B (en) 1993-08-30
EP0467954B1 (fr) 1996-05-01
NO913816L (no) 1991-11-26
ATE137403T1 (de) 1996-05-15
CA2050679A1 (fr) 1990-10-01
NO303205B1 (no) 1998-06-15
DE69026820D1 (de) 1996-06-05
JPH04506207A (ja) 1992-10-29
ES2087151T3 (es) 1996-07-16
AU638245B2 (en) 1993-06-24
EP0467954A1 (fr) 1992-01-29
DE69026820T2 (de) 1996-11-28
WO1990011780A1 (fr) 1990-10-18
AU5434590A (en) 1990-11-05
HUT59818A (en) 1992-07-28
CA2050679C (fr) 1998-09-22
NO913816D0 (no) 1991-09-27
EP0467954A4 (en) 1992-06-03
DK0467954T3 (da) 1996-05-28
HU903559D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
HK1000912A1 (en) Preparation of liposome and lipid complex compositions
CA1262093C (fr) Liposomes steroidiens
ES2107668T3 (es) Liposomas, procedimiento para su preparacion y su uso en la elaboracion de un medicamento.
EP0280492A3 (en) Liposome composition and its production
GR3020068T3 (en) Preparation of lipidic microparticles
IE780464L (en) Liposome compositions
AU587232B2 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
EP0290296A3 (en) Liposomal formulations with a high antineoplastic agent/lipid ratio
ES8700933A1 (es) Un metodo para preparar esterol-liposomas
RU2000124317A (ru) Эритропоэтиновая липосомальная дисперсия
CA2227761A1 (fr) Procedes de fabrication des liposomes contenant des photosensibilisateurs d'hydro-monobenzoporphyrine
CA2099771A1 (fr) Poudre de liposomes et de preliposomes polyeniques et methode de preparation
DE69738416T2 (de) Liposomale zubereitungen von indolocarbazol-derivaten
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
FI916120A0 (fi) Foerfarande foer framstaellning av vattenhaltiga liposomsuspensioner som innehaoller ett aktivt aemne.
DE3853079T2 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
JPS5675438A (en) Method for stabilizing aqueous solution of cyanocobalamin
MY134714A (en) Release-controlled somatotropin composition and method for the preparation thereof
KR970042995A (ko) 크산틴 유도체와 리포조옴과의 복합체를 함유하는 피부 침투성이 개선된 인체 세정체 조성물
JPS6431720A (en) Antihyperlipemic agent consisting of pyrimido(2,1-b)benzothiazole derivative

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070328